Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study.
Steel DHW, Patton N, Stappler T, Karia N, Hoerauf H, Patel N, Wachtlin J, Raber T, Kozma-Wiebe P; INJECT study investigators. Steel DHW, et al. Among authors: wachtlin j. Retina. 2021 Feb 1;41(2):266-276. doi: 10.1097/IAE.0000000000002862. Retina. 2021. PMID: 32496343 Free PMC article.
The predictability of ocriplasmin treatment effects: is there consensus among retinal experts? Results from the EXPORT study.
Bertelmann T, Wachtlin J, Mennel S, Koss MJ, Maier MM, Schumann RG, Kazerounian S, Daniel H, Schmitz-Valckenberg S; EXPORT study group. Bertelmann T, et al. Among authors: wachtlin j. Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1359-1367. doi: 10.1007/s00417-017-3657-2. Epub 2017 Apr 7. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28389700
Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.
Paul C, Heun C, Müller HH, Hoerauf H, Feltgen N, Wachtlin J, Kaymak H, Mennel S, Koss MJ, Fauser S, Maier MM, Schumann RG, Mueller S, Chang P, Schmitz-Valckenberg S, Kazerounian S, Szurman P, Lommatzsch A, Bertelmann T. Paul C, et al. Among authors: wachtlin j. Br J Ophthalmol. 2018 Aug;102(8):1092-1097. doi: 10.1136/bjophthalmol-2017-310874. Epub 2017 Oct 31. Br J Ophthalmol. 2018. PMID: 29089354
[Retinal laser treatment-avoiding mistakes].
Framme C, Hoerauf H, Wachtlin J, Volkmann I, Bartram M, Junker B, Feltgen N. Framme C, et al. Among authors: wachtlin j. Ophthalmologe. 2020 Feb;117(2):169-188. doi: 10.1007/s00347-019-01035-y. Ophthalmologe. 2020. PMID: 32002621 German.
Importance of continuous treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration-12-month post hoc analysis of the PERSEUS real-world evidence study.
Wachtlin J, Eter N, Hasanbasic Z, Keramas G, Rech C, Sachs H, Schilling H, Wiedemann P, Framme C. Wachtlin J, et al. Graefes Arch Clin Exp Ophthalmol. 2021 Mar;259(3):601-611. doi: 10.1007/s00417-020-04803-8. Epub 2020 Aug 13. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 32789651 Free PMC article.
[Avoiding mistakes in anti-VEGF intravitreal injection therapy].
Framme C, Junker B, Feltgen N, Hoerauf H, Striebe NA, Wachtlin J, Volkmann I. Framme C, et al. Among authors: wachtlin j. Ophthalmologe. 2022 Mar;119(3):309-326. doi: 10.1007/s00347-021-01553-8. Epub 2022 Jan 14. Ophthalmologe. 2022. PMID: 35029746 German.
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Eter N, Mohr A, Wachtlin J, Feltgen N, Shirlaw A, Leaback R; German Ozurdex in RVO Real World Study Group. Eter N, et al. Among authors: wachtlin j. Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):77-87. doi: 10.1007/s00417-016-3431-x. Epub 2016 Jul 26. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27460280 Free PMC article. Clinical Trial.
72 results